What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Virus
Massimo Colombo spends much of his time researching Internal medicine, Gastroenterology, Hepatocellular carcinoma, Hepatitis C and Cirrhosis.
Massimo Colombo has researched Internal medicine in several fields, including Pathology, Immunology and Hepatitis C virus.
His biological study spans a wide range of topics, including Fibrosis, Ribavirin, Liver biopsy and Liver transplantation.
His studies in Hepatocellular carcinoma integrate themes in fields like Hepatitis B, Cancer, Surgery and Carcinoma.
The Hepatitis C study combines topics in areas such as Odds ratio, Endocrinology, Epidemiology and Hepatitis.
His Cirrhosis research integrates issues from Liver disease, Allele, Cohort and Risk factor.
His most cited work include:
- An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. (371 citations)
- Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study (358 citations)
- Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 (328 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Gastroenterology, Hepatocellular carcinoma, Cirrhosis and Hepatitis C.
The various areas that Massimo Colombo examines in his Internal medicine study include Ribavirin, Hepatitis C virus, Immunology and Oncology.
His research investigates the connection between Gastroenterology and topics such as Hepatitis B that intersect with issues in Hepatitis B virus.
His Hepatocellular carcinoma study combines topics in areas such as Viral hepatitis, Carcinoma, Pathology and Surgery.
His studies deal with areas such as Fibrosis, Cancer, Radiology and Hepatitis as well as Cirrhosis.
His Hepatitis C study incorporates themes from Interferon alfa, Alpha interferon, Tolerability and Sofosbuvir.
He most often published in these fields:
- Internal medicine (58.63%)
- Gastroenterology (42.86%)
- Hepatocellular carcinoma (34.32%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (58.63%)
- Gastroenterology (42.86%)
- Hepatocellular carcinoma (34.32%)
In recent papers he was focusing on the following fields of study:
Massimo Colombo focuses on Internal medicine, Gastroenterology, Hepatocellular carcinoma, Hepatitis C and Cirrhosis.
His research integrates issues of Surgery, Oncology and Hepatitis C virus in his study of Internal medicine.
His Gastroenterology study which covers Adverse effect that intersects with Renal function.
His biological study spans a wide range of topics, including Hepatitis B and Prospective cohort study, Pathology.
The various areas that Massimo Colombo examines in his Hepatitis C study include Tolerability, Ribavirin, Sofosbuvir and Hepatitis.
His Cirrhosis research incorporates elements of Fibrosis, Mortality rate, Incidence and Hepatology.
Between 2014 and 2021, his most popular works were:
- Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study (358 citations)
- Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 (328 citations)
- Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial (321 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Internal medicine, Hepatocellular carcinoma, Gastroenterology, Cirrhosis and Hepatitis C are his primary areas of study.
His work carried out in the field of Internal medicine brings together such families of science as Pathology, Surgery and Hepatitis C virus.
As a part of the same scientific family, Massimo Colombo mostly works in the field of Hepatocellular carcinoma, focusing on Hepatitis B and, on occasion, Entecavir, NKG2D, HBsAg and Hepatitis B virus.
His Gastroenterology research is multidisciplinary, incorporating elements of Decompensation, Liver transplantation, Cumulative incidence and Sorafenib.
He combines subjects such as Mortality rate, Steatohepatitis and Cohort with his study of Cirrhosis.
Massimo Colombo has researched Hepatitis C in several fields, including Tolerability, Ribavirin, Sofosbuvir and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
